MAGI2 and acute myeloid leukemia: In a study by Chen et al. MAGI2‐AS3 was found to be significantly downregulated in AML LSCs compared to healthy HSC controls, and overexpression of MAGI2‐AS3 inhibited the colony‐forming and self‐renewal ability of LSCs.